Equibles does not estimate personal net worth.
Get an email with a short summary when Boston Scientific Corp publishes a filing, an earnings call transcript or a press release.
Get BSX alertsKen Stein has spoken on 3 earnings calls and 2 other investor events across 1 company, most recently for Boston Scientific Corp on October 28, 2026. Boston Scientific Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Boston Scientific Corp includes Michael Mahoney (CEO), Jonathan Monson (CFO), Joe Fitzgerald (COO) and 7 others.
“So, you know, there was data from a competitor released last year, you know, that I think called into question the broad use of mechanical circulatory support for high-risk PCI.”
“And then I think, you know, some of the confusion around CHAMPION certainly hasn't helped with that. We have seen, for instance, a much greater use of this so-called ablate and wait strategy in patients with a CHASVAS score of three following ablation.”
“I think we are still very firm believers in the strength of clinical evidence, and as a result, the long-term health of this market. Again, the things that Mike talked about, we do think are all transitory, right?”
“I don't have too much to add, but again, I think the first thing I'd say in terms of question, it just takes time to disseminate data and to educate physicians on the results of things like Champion.”
“This is obviously a very exciting time for us. Presented two very high-quality randomized trials, both of which have the potential to be practice transforming. Before we get into those, I want to begin just a high-level overview of where we stand right now with our cardiovascular group.”
Source not stated
Medical Devices · Healthcare
